Literature DB >> 2729931

Cell-wall-defective variants of Fusobacterium.

C C Johnson1, H M Wexler, S Becker, M Garcia, S M Finegold.   

Abstract

The activity of antimicrobial agents against Fusobacterium species has been reported as variable in the literature. For some strains, the inconsistency arises from difficulty in determining the endpoint of growth in agar dilution susceptibility tests. Certain strains persist as a subtle haze beyond the levels of antibiotic that permit conventional colonial growth. We have determined by light and electron microscopy that this haze represents the colonial growth of cell-wall-defective (CWD) variants of the parent Fusobacterium. The CWD forms could be propagated indefinitely in hypertonic medium containing the antibiotic inducing agent. However, when the antibiotic was eliminated, the organisms would revert to their native morphology. Formation of CWD variants was observed in the presence of cell-wall-active drugs (e.g., beta-lactam agents) but not with drugs that work by a different mechanism (e.g., clindamycin or chloramphenicol). Fourteen of 22 F. varium strains, 8 of 11 F. mortiferum strains, 2 of 10 F. gonidiaformans strains, and 1 of 4 of F. necrophorum strains could be induced to a CWD form in vitro in the usual agar dilution susceptibility test. Although the clinical significance of CWD variants of Fusobacterium is unknown, they may be a source of confusion in interpreting agar dilution susceptibility tests.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729931      PMCID: PMC171495          DOI: 10.1128/AAC.33.3.369

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  The Significance of Pleomorphism in Bacteroides Strains.

Authors:  L Dienes; W E Smith
Journal:  J Bacteriol       Date:  1944-08       Impact factor: 3.490

2.  Genetic transfer of the stable L form state to intact bacterial cells.

Authors:  P B Wyrick; M McConnell; H J Rogers
Journal:  Nature       Date:  1973-08-24       Impact factor: 49.962

3.  Acute and recurrent thromboembolic disease: a new concept of etiology.

Authors:  W A Altemeier; E O Hill; W D Fullen
Journal:  Ann Surg       Date:  1969-10       Impact factor: 12.969

4.  Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli.

Authors:  V L Sutter; S M Finegold
Journal:  Appl Microbiol       Date:  1971-01

5.  L forms and bactericidal antibiotic activity.

Authors:  J W Shands
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

6.  Hepatic lesions and bacterial changes in mice during infection of Fusobacterium necrophorum.

Authors:  M M Garcia; K M Charlton; K A McKay
Journal:  Can J Microbiol       Date:  1977-10       Impact factor: 2.419

7.  Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.

Authors:  H Wexler; W T Carter; B Harris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

8.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

9.  Protoplast formation and regeneration of dehydrodivanillin-degrading strains of Fusobacterium varium and Enterococcus faecium.

Authors:  W Chen; K Ohmiya; S Shimizu
Journal:  Appl Environ Microbiol       Date:  1986-10       Impact factor: 4.792

Review 10.  Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera.

Authors:  W L George; B D Kirby; V L Sutter; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1981 May-Jun
View more
  9 in total

1.  beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.

Authors:  E Könönen; A Kanervo; K Salminen; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Statistical analysis of the effects of trial, reader, and replicates on MIC determination for cefoxitin.

Authors:  H M Wexler; P T Lavin; E Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species.

Authors:  J S Brazier; E J Goldstein; D M Citron; M I Ostovari
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 4.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

5.  Comparison of spiral gradient and conventional agar dilution for susceptibility testing of anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; F Jashnian; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

6.  Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation.

Authors:  H M Wexler; E Molitoris; P R Murray; J Washington; R J Zabransky; P H Edelstein; S M Finegold
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Morphological response of Bilophila wadsworthia to imipenem: correlation with properties of penicillin-binding proteins.

Authors:  P Summanen; H M Wexler; K Lee; S A Becker; M M Garcia; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Evaluation of the E test for susceptibility testing of anaerobic bacteria.

Authors:  D M Citron; M I Ostovari; A Karlsson; E J Goldstein
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination.

Authors:  P Summanen; H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.